Join TransCode Therapeutics' Live Investor Webinar: Advancing a Multi-Platform Oncology Pipeline Targeting Metastatic Cancer

Go back to Join TransCode Therapeutics' Live Investor Webinar: Advancing a Multi-Platform Oncology Pipeline Targeting Metastatic Cancer
(NASDAQ: RNAZ) Delayed: 1.74 +0.08 (4.82%)
Previous Close $1.66    52 Week High $ 
Open $1.62    52 Week Low $ 
Day High $1.80    P/E N/A 
Day Low $1.62    EPS $ 
Volume 20,641